Josef Hummelsberger
Josef Hummelsberger has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- R. Nögel
Praxis Prof. Hempen
63 shared publications - C. Hu
Chengdu University
62 shared publications - Ute Engelhardt
München, Deutschland
62 shared publications - Benno Brinkhaus
Institute of Social Medicine, Epidemiology and Health Economics, Charité—University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany
4 shared publications - Miriam Ortiz
Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
3 shared publications - Stefan N. Willich
Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Berlin, Germany
3 shared publications
Latest Publications
- 27 February 2025
- Published by Springer Nature in Chinesische Medizin / Chinese Medicine
- Vol. 40 (1) , 38-39
Bericht vom „ECIM (European Congress of Integrative Medicine) 2024 – Akupunktur und integrative Medizin im Fokus“ mit SMS-Beteiligung
- 27 February 2025
- Published by Springer Nature in Chinesische Medizin / Chinese Medicine
- Vol. 40 (1) , 38-39
Bericht vom „ECIM (European Congress of Integrative Medicine) 2024 – Akupunktur und integrative Medizin im Fokus“ mit SMS-Beteiligung
- 19 February 2025
- Published by Springer Nature in Chinesische Medizin / Chinese Medicine
- Vol. 40 (1) , 40-41
Bericht über die Gründungsveranstaltung des Huxiang TCM Kulturzentrums Deutschland
- 19 February 2025
- Published by Springer Nature in Chinesische Medizin / Chinese Medicine
- Vol. 40 (1) , 40-41
Bericht über die Gründungsveranstaltung des Huxiang TCM Kulturzentrums Deutschland
- 2 February 2024
- Published by Georg Thieme Verlag KG in Zeitschrift für Komplementärmedizin
- Vol. 16 (01) , 64-68
Chinesische Arzneimitteltherapie bei Infekten
Summary: Für viele Ärzt*innen und Therapeut*innen ist die chinesische Arzneimitteltherapie wegen der großen Anzahl von Arzneimitteln und Rezepturen möglicherweise etwas abschreckend. Die Behandlung von Erkältungskrankheiten und Infekten ist jedoch relativ einfach, die chinesische Arzneimitteltherapie hervorragend und schnell wirksam, der Erfolg für Ärzt*innen und Patient*innen offensichtlich. Und auch bei neuen viralen Infekten wie Covid-19 wirken die bekannten Rezepturen, da sie nicht erreger-, sondern syndromspezifisch angewendet werden.
- 2 February 2024
- Published by Georg Thieme Verlag KG in Zeitschrift für Komplementärmedizin
- Vol. 16 (01) , 64-68
Chinesische Arzneimitteltherapie bei Infekten
Summary: Für viele Ärzt*innen und Therapeut*innen ist die chinesische Arzneimitteltherapie wegen der großen Anzahl von Arzneimitteln und Rezepturen möglicherweise etwas abschreckend. Die Behandlung von Erkältungskrankheiten und Infekten ist jedoch relativ einfach, die chinesische Arzneimitteltherapie hervorragend und schnell wirksam, der Erfolg für Ärzt*innen und Patient*innen offensichtlich. Und auch bei neuen viralen Infekten wie Covid-19 wirken die bekannten Rezepturen, da sie nicht erreger-, sondern syndromspezifisch angewendet werden.
- Open Access
- 12 October 2023
- Published by Springer Nature in Chinesische Medizin / Chinese Medicine
- p. 1
Erinnerung an Jochen Gleditsch
- 12 October 2023
- Published by Springer Nature in Chinesische Medizin / Chinese Medicine
- p. 1
Open AccessErinnerung an Jochen Gleditsch
- Open Access
- 30 June 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (26) , e34046
Hydrotherapy and acupressure in restless legs syndrome: A randomized, controlled, 3-armed, explorative clinical trial
Background: Restless legs syndrome (RLS) is a common neurological disease that has a significant impact on daily activities and quality of life, for which there is often no satisfactory therapy. Complementary medicine, such as acupressure and hydrotherapy, is used to treat patients with RLS; however, the clinical evidence is unclear. This study aims to investigate the effects and feasibility of self-administered hydrotherapy and acupressure in patients with RLS. Methods: This is a randomized, controlled, open-label, exploratory, clinical study with 3 parallel arms, comparing both self-applied hydrotherapy (according to the German non-medical naturopath Sebastian Kneipp) and acupressure in addition to routine care in comparison to routine care alone (waiting list control) in patients with RLS. Fifty-one patients with at least moderate restless-legs syndrome will be randomized. Patients in the hydrotherapy group will be trained in the self-application of cold knee/lower leg affusions twice daily for 6 weeks. The acupressure group will be trained in the self-application of 6-point-acupressure therapy once daily for 6 weeks. Both interventions take approximately 20 minutes daily. The 6-week mandatory study intervention phase, which is in addition to the patient preexisting routine care treatment, is followed by a 6-week follow-up phase with optional interventions. The waitlist group will not receive any study intervention in addition to their routine care before the end of week 12. Outcome parameters including RLS-severity, disease and health-related quality of life (RLS-QoL, SF-12), Hospital Anxiety and Depression Score in German version, general self-efficacy scale, and study intervention safety will be measured at baseline and after 6 and 12 weeks. The statistical analyses will be descriptive and exploratory. Conclusion: In the case of clinically relevant therapeutic effects, feasibility, and therapeutic safety, the results will be the basis for planning a future confirmatory randomized trial and for helping to develop further RLS self-treatment concepts.
- 30 June 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (26) , e34046
Open AccessHydrotherapy and acupressure in restless legs syndrome: A randomized, controlled, 3-armed, explorative clinical trial
Background: Restless legs syndrome (RLS) is a common neurological disease that has a significant impact on daily activities and quality of life, for which there is often no satisfactory therapy. Complementary medicine, such as acupressure and hydrotherapy, is used to treat patients with RLS; however, the clinical evidence is unclear. This study aims to investigate the effects and feasibility of self-administered hydrotherapy and acupressure in patients with RLS. Methods: This is a randomized, controlled, open-label, exploratory, clinical study with 3 parallel arms, comparing both self-applied hydrotherapy (according to the German non-medical naturopath Sebastian Kneipp) and acupressure in addition to routine care in comparison to routine care alone (waiting list control) in patients with RLS. Fifty-one patients with at least moderate restless-legs syndrome will be randomized. Patients in the hydrotherapy group will be trained in the self-application of cold knee/lower leg affusions twice daily for 6 weeks. The acupressure group will be trained in the self-application of 6-point-acupressure therapy once daily for 6 weeks. Both interventions take approximately 20 minutes daily. The 6-week mandatory study intervention phase, which is in addition to the patient preexisting routine care treatment, is followed by a 6-week follow-up phase with optional interventions. The waitlist group will not receive any study intervention in addition to their routine care before the end of week 12. Outcome parameters including RLS-severity, disease and health-related quality of life (RLS-QoL, SF-12), Hospital Anxiety and Depression Score in German version, general self-efficacy scale, and study intervention safety will be measured at baseline and after 6 and 12 weeks. The statistical analyses will be descriptive and exploratory. Conclusion: In the case of clinically relevant therapeutic effects, feasibility, and therapeutic safety, the results will be the basis for planning a future confirmatory randomized trial and for helping to develop further RLS self-treatment concepts.
- 1 February 2022
- Published by Springer Nature in Deutsche Zeitschrift für Akupunktur
- Vol. 65 (1) , 22-27
The treatment of fibromyalgia syndrome (FMS) with (traditional) Chinese medicine (TCM)
- 1 February 2022
- Published by Springer Nature in Deutsche Zeitschrift für Akupunktur
- Vol. 65 (1) , 22-27
The treatment of fibromyalgia syndrome (FMS) with (traditional) Chinese medicine (TCM)
- 30 September 2021
- Published by Springer Nature in Chinesische Medizin / Chinese Medicine
- Vol. 36 (3) , 126-133
Chinesische Medizin zur Vorbeugung und Behandlung der Demenz
- 30 September 2021
- Published by Springer Nature in Chinesische Medizin / Chinese Medicine
- Vol. 36 (3) , 126-133
Chinesische Medizin zur Vorbeugung und Behandlung der Demenz
- Open Access
- 26 February 2021
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-12
Acupuncture in diabetic peripheral neuropathy—protocol for the randomized, multicenter ACUDPN trial
Background: Acupuncture is used to treat patients with diabetic peripheral neuropathy; however, the evidence is unclear. We present the design and methodology of the ACUDPN (ACUpuncture in Diabetic Peripheral Neuropathy) trial, which investigates the effectiveness of acupuncture for the treatment of diabetic peripheral neuropathy (DPN) symptoms. The aim of this study is to investigate whether acupuncture is effective for the treatment of DPN symptoms. Methods: This study is a two-armed, randomized, controlled, parallel group, open-label, confirmatory, multicenter trial (8-week intervention period plus 16 weeks of follow-up). Physicians in outpatient units in Germany who specialize in acupuncture treatment will treat 110 diabetes type II patients with clinical symptoms of peripheral neuropathy in the feet and legs with signs of neuropathy according to nerve conduction testing. The patients will be randomized in a 1:1 ratio to one of the following two groups: (a) semi-standardized acupuncture plus routine care or (b) routine care alone. Acupuncture will consist of 12 treatments per patient over 8 weeks. The primary outcome will be the overall DPN-related complaints in the extremities after 8 weeks as measured by the Visual Analog Scale (VAS). Further outcome measures will include DPN-related pain, the Neuropathic Pain Symptom Inventory (NPSI), Diabetic Peripheral Neuropathic Pain Impact (DPNPI) scores, and nerve conduction parameters of the sural nerve at weeks 8, 16, and 24. Discussion: The results of this trial will be available in 2021 and will help clarify whether acupuncture can be considered effective for the treatment of DPN with regard to the subdimensions of the neuropathic clinical picture. Trial registration: ClinicalTrials.gov NCT03755960. Registered on 11 August 2018.
- 26 February 2021
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-12
Open AccessAcupuncture in diabetic peripheral neuropathy—protocol for the randomized, multicenter ACUDPN trial
Background: Acupuncture is used to treat patients with diabetic peripheral neuropathy; however, the evidence is unclear. We present the design and methodology of the ACUDPN (ACUpuncture in Diabetic Peripheral Neuropathy) trial, which investigates the effectiveness of acupuncture for the treatment of diabetic peripheral neuropathy (DPN) symptoms. The aim of this study is to investigate whether acupuncture is effective for the treatment of DPN symptoms. Methods: This study is a two-armed, randomized, controlled, parallel group, open-label, confirmatory, multicenter trial (8-week intervention period plus 16 weeks of follow-up). Physicians in outpatient units in Germany who specialize in acupuncture treatment will treat 110 diabetes type II patients with clinical symptoms of peripheral neuropathy in the feet and legs with signs of neuropathy according to nerve conduction testing. The patients will be randomized in a 1:1 ratio to one of the following two groups: (a) semi-standardized acupuncture plus routine care or (b) routine care alone. Acupuncture will consist of 12 treatments per patient over 8 weeks. The primary outcome will be the overall DPN-related complaints in the extremities after 8 weeks as measured by the Visual Analog Scale (VAS). Further outcome measures will include DPN-related pain, the Neuropathic Pain Symptom Inventory (NPSI), Diabetic Peripheral Neuropathic Pain Impact (DPNPI) scores, and nerve conduction parameters of the sural nerve at weeks 8, 16, and 24. Discussion: The results of this trial will be available in 2021 and will help clarify whether acupuncture can be considered effective for the treatment of DPN with regard to the subdimensions of the neuropathic clinical picture. Trial registration: ClinicalTrials.gov NCT03755960. Registered on 11 August 2018.
- 9 December 2020
- Published by Springer Nature in Chinesische Medizin / Chinese Medicine
- Vol. 35 (4) , 225-235
Traditionelle Chinesische Medizin (TCM) — vom Mythos zur Evidenz
- 9 December 2020
- Published by Springer Nature in Chinesische Medizin / Chinese Medicine
- Vol. 35 (4) , 225-235
Traditionelle Chinesische Medizin (TCM) — vom Mythos zur Evidenz